SDGR - Schrodinger tumbles 8% on Q1 misses; drug discovery revenue plummets
2024-05-01 17:12:41 ET
More on Schrödinger
- Schrodinger: Conservative Guidance Sets The Stock Up For A Solid 2024
- Schrödinger, Inc. (SDGR) Q4 2023 Earnings Call Transcript
- Schrödinger misses top-line and bottom-line estimates; initiates Q2 and reaffirms FY24 outlook
- Schrödinger Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Schrödinger